x10 Treatment options in late-life treatment-resistant depression
from Psychiatric Times
From May 31:
Depression is a major public health issue and is associated with significant morbidity, mortality, and economic burden. It is the third-greatest contributor to global disease burden1 and affects both low- and high-income countries, with a 12-month prevalence of 5.9 percent and 5.5 percent, respectively. There is a relative paucity of information on treatment of late-life treatment-resistant depression.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063